SCHEMBL9980411

SCHEMBL9980411

COc1ccc(S(N)(=O)=O)cc1CNc1ncnc2[nH]nc(-c3ccoc3)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 10/20 0.45
CYP3A4 P08684 10/20 0.45
CYP2D6 P10635 10/20 0.45
CYP2C19 P33261 10/20 0.45
USP2 O75604 9/20 0.45
TSHR P16473 9/20 0.45
HSD17B10 Q99714 8/20 0.45
ALDH1A1 P00352 7/20 0.45
MEN1 O00255 7/20 0.45
KMT2A Q03164 7/20 0.45
CLK4 Q9HAZ1 6/20 0.45
LMNA P02545 6/20 0.45
MAPK1 P28482 4/20 0.45
HIF1A Q16665 2/20 0.45
CYP2C9 P11712 5/20 0.43
ALOX15 P16050 3/20 0.43
MAPT P10636 3/20 0.43
TDP1 Q9NUW8 3/20 0.43
KDM4E B2RXH2 3/20 0.43
GLA P06280 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9980382 0.91 USP2 (0.36) CYP1A2CYP3A4CYP2D6CYP2C19USP2
SCHEMBL9980383 0.84 LMNA (0.41) LMNAMAPK1MAPTTTKMAPK8
SCHEMBL9980486 0.81 FFAR2 (0.33) CYP1A2CYP3A4CYP2D6CYP2C19USP2
SCHEMBL12067895 0.79 TNNI3K (0.55)
SCHEMBL9980405 0.76 CCNB2 (0.34) CLK4LMNAMAPTMAPK8CA1
SCHEMBL1809500 0.73 BRAF (0.53) CYP1A2CYP3A4CYP2D6CYP2C19USP2
SCHEMBL12065551 0.72 TNNI3K (0.44)
SCHEMBL19507742 0.71 TTK (0.43) CYP1A2CYP3A4CYP2D6CYP2C19USP2
SCHEMBL9980375 0.70 TNNI3K (0.40) ALDH1A1LMNAMAPTSMN1; SMN2CA1
SCHEMBL19507719 0.69 ALDH1A1 (0.44) CYP1A2CYP3A4CYP2D6CYP2C19USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011149827-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-12-01 WO claimed
WO-2011149827-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-12-01 WO disclosed